These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8750616)
21. [Serum concentration of creatine kinase in children as an indicator of myocardial damage in the course of virus hepatitis]. Taraszkiewicz F Pediatr Pol; 1969 Apr; 44(4):455-8. PubMed ID: 5792020 [No Abstract] [Full Text] [Related]
22. Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX. Ondruskova N; Honzik T; Kolarova H; Pakanova Z; Mucha J; Zeman J; Hansikova H Metabolism; 2018 May; 82():135-141. PubMed ID: 29408683 [No Abstract] [Full Text] [Related]
23. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area. Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176 [TBL] [Abstract][Full Text] [Related]
24. High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia. Cherif W; Ben Rhouma F; Messai H; Mili A; Gribaa M; Kefi R; Ayadi A; Boughamoura L; Chemli J; Saad A; Kaabachi N; Sfar MT; Ben Dridi MF; Tebib N; Abdelhak S Ann Biol Clin (Paris); 2012; 70(6):648-50. PubMed ID: 23207808 [TBL] [Abstract][Full Text] [Related]
26. Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations. Aoyama Y; Ozer I; Demirkol M; Ebara T; Murase T; Podskarbi T; Shin YS; Gokcay G; Okubo M J Hum Genet; 2009 Nov; 54(11):681-6. PubMed ID: 19834502 [TBL] [Abstract][Full Text] [Related]
27. [Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis]. Fukuda T; Sugie H; Ito M; Tsurui S; Sugie Y; Igarashi Y Rinsho Shinkeigaku; 1996 Apr; 36(4):540-3. PubMed ID: 8810846 [TBL] [Abstract][Full Text] [Related]
28. Genetic analysis and clinical assessment of four patients with Glycogen Storage Disease Type IIIa in China. Zhang Y; Xu M; Chen X; Yan A; Zhang G; Liu Z; Qiu W BMC Med Genet; 2018 Apr; 19(1):54. PubMed ID: 29614965 [TBL] [Abstract][Full Text] [Related]
29. Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations. Rossi A; Hoogeveen IJ; Bastek VB; de Boer F; Montanari C; Meyer U; Maiorana A; Bordugo A; Dianin A; Campana C; Rigoldi M; Kishnani PS; Pendyal S; Strisciuglio P; Gasperini S; Parenti G; Parini R; Paci S; Melis D; Derks TGJ J Inherit Metab Dis; 2020 Jul; 43(4):770-777. PubMed ID: 32064649 [TBL] [Abstract][Full Text] [Related]
30. A case of Costello syndrome and glycogen storage disease type III. Kaji M; Kurokawa K; Hasegawa T; Oguro K; Saito A; Fukuda T; Ito M; Sugie H J Med Genet; 2002 Feb; 39(2):E8. PubMed ID: 11836377 [No Abstract] [Full Text] [Related]
31. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III. Oh SH; Park HD; Ki CS; Choe YH; Lee SY Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866 [TBL] [Abstract][Full Text] [Related]
32. Glycogen storage disease type I and III and pyruvate carboxylase deficiency: results of long-term treatment with uncooked cornstarch. Ullrich K; Schmidt H; van Teeffelen-Heithoff A Acta Paediatr Scand; 1988 Jul; 77(4):531-6. PubMed ID: 3134793 [TBL] [Abstract][Full Text] [Related]
33. [Case of glycogenosis III with marked fibrosis of the myocardium and cardiac failure]. Toyota H; Kurokawa S; Tanaka H; Baba S; Kobayashi M; Nakaya R; Kawanishi M Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):583. PubMed ID: 1619340 [No Abstract] [Full Text] [Related]
34. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III. Mogahed EA; Girgis MY; Sobhy R; Elhabashy H; Abdelaziz OM; El-Karaksy H Eur J Pediatr; 2015 Nov; 174(11):1545-8. PubMed ID: 25948107 [TBL] [Abstract][Full Text] [Related]
35. A neonatal form of glycogen storage disease type IV. Nambu M; Kawabe K; Fukuda T; Okuno TB; Ohta S; Nonaka I; Sugie H; Nishino I Neurology; 2003 Aug; 61(3):392-4. PubMed ID: 12913206 [TBL] [Abstract][Full Text] [Related]
36. Peripheral neuropathy in glycogen storage disease type III: Fact or myth? Herlin B; Laforět P; Labrune P; Fournier E; Stojkovic T Muscle Nerve; 2016 Feb; 53(2):310-2. PubMed ID: 26575860 [TBL] [Abstract][Full Text] [Related]
37. Lens opacities in glycogenoses type I and III. Allegrini D; Autelitano A; Fogagnolo P; De Cillà S; Piozzi E; Mazza M; Paci S; Montanari C; Riva E; Rossetti L Can J Ophthalmol; 2015 Dec; 50(6):480-4. PubMed ID: 26651310 [TBL] [Abstract][Full Text] [Related]
38. Glycogen storage disease in Israel. A clinical, biochemical and genetic study. Levin S; Moses SW; Chayoth R; Jagoda N; Steinitz K Isr J Med Sci; 1967; 3(3):397-410. PubMed ID: 5317551 [No Abstract] [Full Text] [Related]
39. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Lee PJ; Deanfield JE; Burch M; Baig K; McKenna WJ; Leonard JV Am J Cardiol; 1997 Mar; 79(6):834-8. PubMed ID: 9070576 [TBL] [Abstract][Full Text] [Related]
40. Radiography of glycogen storage diseases. Miller JH; Stanley P; Gates GF AJR Am J Roentgenol; 1979 Mar; 132(3):379-87. PubMed ID: 106640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]